Shoulder pain leads to Texas dad’s cancer diagnosis: “I was like, ‘Wait, what?'”
Shoulder Pain Leads to Texas Dad's Cancer Diagnosis: "I Was Like, 'Wait, What?'"
Shoulder pain leads to Texas dad s - For Texas resident Eric Dillon, a routine shoulder ache became the unexpected gateway to a multiple myeloma diagnosis. The journey began when he noticed persistent discomfort in his shoulder, initially attributing it to a rotator cuff strain. After visiting an orthopedic specialist and undergoing physical therapy, the pain lingered, resurfacing with changes in posture or activity. This pattern shifted in May 2024 when intense shoulder pain during yard work in his Houston home prompted a new medical evaluation, leading to a surprising discovery.
Dillon’s visit to the orthopedist culminated in an MRI that revealed an unexpected diagnosis. The results prompted a referral to an oncologist, a transition he hadn’t anticipated. "I walked in, and she was like, 'You know why you're here?' I was like, 'I've got a referral from another doctor to see you,'" he recounted. The oncologist, an orthopedic oncologist, explained that the disease could be the root cause. "Wait, what?" Dillon exclaimed, realizing the shoulder pain was a subtle sign of something more serious.
“It was a wake-up call,” Dillon said, reflecting on how the pain had been a silent indicator of multiple myeloma.
Multiple myeloma, a type of blood cancer targeting plasma cells, can weaken bones and disrupt blood production, leading to complications like anemia and kidney damage. Dillon’s shoulder pain, once thought to be a musculoskeletal issue, was actually a symptom of this systemic disease. The initial misdiagnosis highlights how shoulder pain can mask more severe conditions, particularly in Texas patients where early detection remains a challenge.
Understanding Multiple Myeloma
Dr. Hearn Cho, an oncologist and chief medical officer at the Multiple Myeloma Research Foundation, explained the disease’s progression. "Multiple myeloma affects plasma cells, which produce antibodies," Cho said. When these cells become cancerous, they multiply uncontrollably, causing bone degradation and systemic symptoms. This can manifest as localized pain in areas like the shoulder or spine, often mistaken for arthritis or strain.
Cho noted that shoulder pain is frequently overlooked as a red flag for multiple myeloma. "Doctors are trained to consider the most common causes first," he explained. "That’s why patients with Texas-based symptoms might be misdiagnosed initially. It can take time to uncover the underlying issue." The disease’s prevalence in certain communities, like Black patients who account for 20% of cases despite making up only 4% of the U.S. population, underscores the importance of recognizing shoulder pain as a potential early symptom.
The Clinical Trial Experience
Once diagnosed, Dillon joined a clinical trial at MD Anderson Cancer Center, a decision that offered both personal and scientific benefits. "I signed up with no hesitation," he said. The trial provided a sense of empowerment and deeper understanding of his condition, while also contributing to broader research efforts. For Texas patients, clinical trials can be a critical avenue for advanced treatment options, especially in cases where traditional diagnoses fall short.
Dillon’s participation in the trial spanned nearly a year, during which he balanced his role as an engineering consultant with eight cycles of therapy. He documented his progress daily, tracking side effects and treatment outcomes. "It was rewarding to see how my involvement helped shape the trial," Dillon said. The regimen eventually brought relief, though some cancer cells persisted in his shoulder bone, requiring additional radiation therapy to eliminate the pain.
The experience highlighted the importance of early intervention for Texas residents experiencing shoulder pain. Dillon’s story serves as a reminder that what may seem like a minor ailment could signal a life-threatening condition. "Even if you're not feeling sick, shoulder pain can be a key symptom," Cho emphasized. For patients in Texas, timely diagnosis and participation in clinical trials can make a significant difference in managing multiple myeloma.